Table of Contents
- Introduction
- From Toxins To Genomics: The Expanding Scope Of Environmental Health
- Wastewater Epidemiology: The New Frontier In Public Health
- Wastewater Surveillance Requires More Than Testing. It Requires Innovation.
- Unearthing New Microbial Frontiers
- Sequencing the UAE’s Ecological Soul & Heritage: The GHAF Tree Project
- A Lab Built from Imagination, Grit, and Serendipity.
- Designing the Future of Environmental Health
Introduction
Four years ago, a barren plot of land in Abu Dhabi held no clues to the rapidly growing scientific platform it would soon become. With a bold vision to explore the non-clinical drivers of health and a deliberate mandate to operate at the intersection of public health, environmental science and advanced technology, M42 launched its Environmental Sciences (EVS) division. EVS is a first-of-its-kind department focused on environmental drivers of health, with a bold vision, expert talent and state-of-the-art technology. It collaborated with the Abu Dhabi Quality and Conformity Council (ADQCC). Together, they built not just a laboratory, but a paradigm shift: one that sees the environment not as background noise, but a rich data layer that can be used to safeguard public health and safety and its intricate relationship with the environment.
The result is RASID: a cutting-edge laboratory and scientific institution that has established a growing international presence, with connections to leading local and global academic institutions. It stands as a living model of integrated science, policy and innovation. Its very existence is proof of what’s possible when ambition meets execution.
“We built something extraordinary, from the ground up, in just 18 months, we launched one of the world’s largest and most advanced mass spectrometry labs.” says Dr. Bhuvaneshkumar Shanmugam, Senior Microbiologist & Lab Manager, Environmental Sciences, M42. “The lab has many mass spectrometers, sample preparation robots and AI based detection technologies with high sample throughput along with high scope of testing in very ergonomic space. And footprint. The lab is also accredited with ISO 17025 standard and Green lab certification following internationally recognized such as GAPI, AGREE, BAGI, RAPI”
From Toxins to Genomics: the Expanding Scope of Environmental Health
M42’s EVS division explores the often-invisible factors that shape population health, from airborne toxins and antimicrobial resistance to biological & chemical surveillance, food systems and marine ecosystems.
At its core is data driven. An AI-enhanced approach helps transform complex environmental signals into actionable insights. Through advanced lab design, regulatory-grade testing, genomic analysis, R&D and scientific publishing, EVS is not just reacting to environmental risks, it aims to anticipate emerging environmental risks.
“Many talk about intent. We focus on execution,” says Dr. Shanmugam. “To date, we have delivered over 40 scientific and technical contributions (book chapters, research/review/editorial articles and application notes) that were presented at global and local forums.”
Wastewater Epidemiology: the New Frontier in Public Health
Wastewater surveillance is fast becoming an essential global tool for monitoring public health & safety threats. EVS is at the vanguard of this shift.
Wastewater analysis was originally used to track pathogens transmitted via the fecal-oral route. It is now a cost-effective, population-level surveillance tool capable of detecting infectious diseases early and tracking viral mutations, chemical hazards and it is also guiding real-time interventions.
“We are building what I believe aims to become a global reference point for wastewater-based epidemiology,” Dr Shanmugam notes. “We’re not just studying it; we’re shaping the science itself.”
During the COVID-19 pandemic, wastewater-based epidemiology proved indispensable on a global level. It played a central role in gauging community infection trends, tracking viral mutations, and pinpointing emerging hotspots – all without the need for widespread individual testing. Now, EVS is using the same infrastructure to monitor a broader array of threats.
Wastewater Surveillance Requires More Than Testing. It Requires Innovation.
Wastewater represents one of the most technically challenging sample types in modern laboratory science. Unlike controlled clinical specimens, it is a heterogeneous mixture where pathogens, chemicals, inhibitors, and environmental factors interact continuously. Detecting microorganisms at low abundance while maintaining analytical sensitivity and accuracy demands specialized expertise.
Expanding wastewater surveillance to include clinically significant pathogens introduces further complexity, as reference methods and established performance criteria may not always exist. Success depends on the ability to adapt, optimize, and scientifically validate methods for real-world environmental conditions. This is where RASID Laboratory excels, combining innovation, scientific rigor, and advanced analytical capabilities to deliver trusted surveillance data that supports public health protection, says Dr. Shanmugam.
Antimicrobial Resistance: A Silent Global Emergency
Among EVS’s most urgent priorities is antimicrobial resistance (AMR) – one of the world’s most pressing public health concerns, responsible for an estimated 1.27 million deaths in 2019, and a contributing factor in nearly 5 million more .
“What makes our wastewater approach unique is its ability to see what clinical sampling often misses,” says Dr. Shanmugam. “We track pathogens that persist in harsh conditions – resistant not just to antibiotics, but to heat, disinfectants, and chemicals. These insights reveal how resistance traits emerge, evolve and spread.
As the team observes AMR, they are helping chart a course to counteract it, with implications for drug development, infection control, and global health policy.
Unearthing New Microbial Frontiers
AMR surveillance is only part of the picture. EVS scientists are also identifying novel microbes, sequencing resistance genes, and cataloging pathogens with pharmaceutical relevance. Their work includes:
- Full whole-genome sequencing of Candida auris from environmental samples and the early identification of a new clade – a first-of-its-kind achievement
- Active surveillance or respiratory syncytial virus (RSV), rhinoviruses, human metapneumovirus, and other respiratory pathogens
“No one knows C. auris’s natural habitat. With only a limited known reported number of complete C. auris genomes available globally—and even fewer originating from environmental sources—our contributions are both unique and urgent.” Dr. Shanmugam said.
Sequencing the UAE’s Ecological Soul & Heritage: the GHAF Tree Project
bsp;Beyond infectious threats, EVS is pioneering work with environmental DNA (eDNA) through projects like the UAE’s native plant species, starting with the GHAF, in collaboration with the Environment Agency of Abu Dhabi.
This effort built on the first full genome sequence of the Ghaf tree (Prosopis cineraria), developed by UAE University and collaborators and published in 2022. Building on that foundation, advanced long-read whole-genome sequencing enabled deeper genomic characterization. In 2024, M42, in collaboration with the Environment Agency – Abu Dhabi (EAD), further advanced this work through deep whole-genome sequencing and analysis, identifying genomic variants and generating new insights into the genetic diversity and adaptive characteristics of the UAE’s national tree.
But the implications extend far beyond the genome itself. EVS is expanding this research across multiple layers of biology—mapping gene expression, investigating protein pathways, and characterizing the microbial and fungal communities that coexist with desert plants. Together, these approaches can provide a more integrated understanding of how desert species survive, adapt, and interact with their extreme environment.
This work could fuel bioprospecting for novel compounds with potential applications in agriculture, medicine, and biotechnology, opening new avenues for scientific discovery and innovation.
A Lab Built from Imagination, Grit, and Serendipity.
“Our greatest strength is our people. Over the years, we have assembled a multidisciplinary team of scientists, microbiologists, molecular biologists, technologists, bioinformaticians, and quality professionals who combine technical expertise with a collaborative mindset. Our team is recognized not only for its scientific capabilities but also for its ability to work together effectively, support one another, and maintain a culture of continuous improvement.
This balance of technical excellence and teamwork has been instrumental in achieving our milestones and building strong relationships with stakeholders, partners, and regulatory authorities in delivering complex projects under demanding timelines” adds Dr. Shanmugam.
Designing the Future of Environmental Health
From early sanitation and drainage systems in ancient Mesopotamia to today’s AI-enabled environmental monitoring and predictive analytics, advances in managing waste and water—and in understanding the microbial world around us—reflect the continuing evolution of public health and environmental management.
For M42’s EVS team, the work underway is only the beginning. What started on an empty plot of land now influences global science, public health preparedness and the very future of environmental medicine.
“This is the spirit of scientific adventure: the joy of asking impossible questions and designing the future with your own hands.”
By accessing, listening to or reading Beyond Bounds content, you acknowledge and agree that the views expressed by guests and contributors are their own and do not necessarily reflect the views of M42.
All content is provided for general informational purposes only and is not intended as, and should not be relied upon as, medical advice, diagnosis or treatment. Always consult a suitably qualified healthcare professional regarding any medical condition or healthcare decision. Accessing Beyond Bounds content does not create a doctor–patient, clinical, advisory or other professional relationship.
References or links to third-party content, products, services or resources are provided for informational purposes only and do not constitute or imply endorsement by M42. To the fullest extent permitted by applicable law, M42 accepts no liability for any loss, damage or other consequence arising from, or in connection with, access to or reliance upon content in Beyond Bounds.
This disclaimer shall be governed by and construed in accordance with the laws of the United Arab Emirates as applicable in the Emirate of Abu Dhabi. Any dispute arising out of or in connection with this disclaimer shall be subject to the exclusive jurisdiction of the courts of the Emirate of Abu Dhabi.